Private Life Sciences Company Call Series
Monday, June 29 – Thursday, July 2, 2020
Virtual
We are pleased to invite you to a virtual call series highlighting the next generation of life sciences private companies from Monday, June 29th – Thursday, July 2nd, 2020. We will be hosting the companies for 35 minute presentations with time for Q&A over the four days.
Participating Companies as of June 18 :
Alpha Tau Medical, Amplo Biotechnology, Artios Pharma Inc., Aruna Bio, Atrin Pharmaceuticals, BioSight Pharma, Cadent Therapeutics, Caribou Biosciences, Carisma Therapeutics, Cingulate Therapeutics, Decibel Therapeutics, Dynacure, Eureka Therapeutics, Excision BioTherapeutics, FogPharma, Foghorn Therapeutics, Glycostem, Immunocore, Intensity Therapeutics, Kuur Therapeutics, Lava Therapeutics, NodThera, Obsidian Therapeutics, Ohana Biosciences, Palvella Therapeutics, ReAlta Life Sciences, Inc., Sensei BioTherapeutics, Shape Therapeutics, Tempest Therapeutics, Triplet Therapeutics, Viramal
Agenda
-
Monday, June 29
Time Company Presenter 1:30 PM ET Artios Pharma Inc.
Click here to join Artios Pharma Inc.Niall Martin, CEO 2:15 PM ET Lava Therapeutics
Click here to join Lava TherapeuticsStephen Hurly, CEO 3:00 PM ET Eureka Therapeutics
Click here to join Eureka TherapeuticsDr. Cheng Liu, President and CEO 3:45 PM ET Obsidian Therapeutics
Click here to join Obsidian TherapeuticsPaul Wotton, CEO
Ryan Daws, CFO4:30 PM ET Tempest Therapeutics
Click here to join Tempest TherapeuticsTom Dubensky, CEO
Steve Brady, President & COO -
Tuesday, June 30
Time Company Presenter 8:00 AM ET Glycostem
Click here to join GlycostemTroels Jordansen, CEO 8:45 AM ET TBA 9:30 AM ET ReAlta Life Sciences, Inc.
Click here to join ReAlta Life SciencesUlrich Thienel, MD, PhD, Chief Executive Officer 10:15 AM ET Excision BioTherapeutics
Click here to join Excision BioTherapeuticsDaniel Dornbusch, CEO 11:00 AM ET Triplet Therapeutics
Click here to join Triplet TherapeuticsNessan Bermingham, Founder, President & CEO 11:45 AM ET Amplo Biotechnology
Click here to join Amplo BiotechnologyPatricio Sepulveda, CEO
Al Hawkins, President12:30 PM ET PANEL: Zooming to a Cure: Oncology BD in the Time of COVID
Click here to join panelPanelists: - Chris Sheldon, Vice President, Global Head of Business Development & Licensing, Oncology R&D, AstraZeneca
- Rachael Lester, VP Corporate Development, Harpoon Therapeutics
- Marc Ceulemans, Head of Strategic Venture Capital Fund, Pharma Equities , Novartis AG
- Niels P. Emmerich, Ph.D., Vice President, Global Head Search and Evaluation, AbbVie
- Derek DiRocco, Ph.D., Principal, Investments, RA Capital Management
- Vanessa Bhark, Senior Associate, Life Sciences, Frazier Healthcare Partners
Oppenheimer Host:
Michael A. Margolis, R.Ph., Co-Head of Healthcare Investment Banking1:30 PM ET Intensity Therapeutics
Click here to join Intensity TherapeuticsLewis H. Bender, CEO
Dr. Ian B. Walters, Chief Medical Officer2:15 PM ET Alpha Tau Medical
Alpha Tau MedicalRaphi Levy, CFO 3:00 PM ET Cingulate Therapeutics
Click here to join Cingulate TherapeuticsShane J. Schaffer, PharmD, Chairman & CEO
Laurie Myers, COO
Lou Van Horn, CFO
Matthew Brams, MD, CMO
Raul Silva, MD, CSO3:45 PM ET Sensei Biotherapeutics
Click here to join Sensei BiotherapeuticsJohn Celebi, President & CEO
Rob Pierce, Chief Scientific Officer
Marie-Louise Fjaellskog, Chief Medical Officer4:30 PM ET FogHorn
Click here to join FogHornAllan Reine, MD, Chief Financial Officer
Adrian Gottschalk, Chief Executive Officer -
Wednesday, July 1
Time Company Presenter 8:00 AM ET NodThera
Click here to join NodTheraAdam Keeney, CEO 8:45 AM ET Immunocore
Click here to join ImmunocoreBahija Jallal, CEO
Brian DiDonato, CFO & Head of Strategy9:30 AM ET Biosight Pharma
Click here to join BioSight PharmaTBA 10:15 AM ET Decibel Therapeutics
Click here to join Decibel TherapeuticsLaurence Reid, CEO 11:00 AM ET Dynacure
Click here to join DynacureStephane Van Rooijen, CEO 11:45 AM ET FogPharma
Click here to join FogPharmaGreg Verdine, Co-Founder & CEO
Tony Gibney, CFO & CBO12:30 PM ET PANEL: Alternative Paths to Going Public
APOs including Reverse Mergers, Form-10s & SPACs
Click here to join panelPanelists: - Jay File, CFO, Evofem Biosciences, Inc. (EVFM)
- Adam Cutler, CFO, Molecular Templates, Inc. (MTEM)
- Scott Morenstein, Managing Director, Life Sciences Investing, CAM Capital
- Keith W. Marshall, Ph.D., M.B.A., Former Executive Vice President, Chief Operating Officer, and Chief Financial Officer, Conatus Pharmaceuticals
- Mike Celano, CFO, Larimar Therapeutics, Inc.
- Vishal Kapoor, President, Amplitude Healthcare Acquisition Company
Oppenheimer Host:
Michael A. Margolis, R.Ph., Co-Head of Healthcare Investment Banking
Stefan Loren, Ph.D., Managing Director, Healthcare Investment Banking1:30 PM ET Carisma Therapeutics
Click here to join Carisma TherapeuticsSteven Kelly, CEO & President 2:15 PM ET Kuur Therapeutics
Click here to join Kuur TherapeuticsKevin S. Boyle, Sr., Chief Executive Officer
Kurt C. Gunter , Chief Medical Officer3:00 PM ET Ohana Biosciences
Click here to join Ohana BiosciencesAmber Salzman, President & CEO 3:45 PM ET Viramal
Click here to join ViramalOliver Bates, CEO 4:30 PM ET Caribou Biosciences
Click here to join Caribou BiosciencesRachel Haurwitz, President and CEO -
Thursday, July 2
Time Company Presenter 8:00 AM ET Atrin
Click here to join AtrinOren Gilad, CEO
Rich Fitzgerald, CFO8:45 AM ET Palvella Therapeutics
Click here to join Palvella TherapeuticsWes Kaupinen, President and CEO 9:30 AM ET Cadent Therapeutics
Click here to join Cadent TherapeuticsJodie Morrison, CEO
John McBride, CFO
Tim Piser, CSO
Chris Kenney, CMO
Nicole Luosey, VP, Strategic and Program Operations10:15 AM ET Aruna Bio
Click here to join Aruna BioMark Sirgo, Chief Executive Officer 11:00 AM ET Shape Therapeutics
Click here to join Shape TherapeuticsFrancois Vigneault, PhD, President and CEO
John Suliman, CFO
For more information, please contact your Oppenheimer institutional sales representative or Financial Professional